The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of U.S. President Donald Trump’s top complaints after he announced steep tariff increases on branded medication.
British Prime Minister Keir Starmer’s chief business adviser, Varun Chandra, will travel to Washington next week, the report added. Reuters could not immediately verify the report.
The president has fumed because prescription drugs cost more in the U.S. than in any other country, often by nearly threefold. He has demanded that drug companies lower prices in the U.S. and raise them elsewhere. The price increases would potentially offset the impact of U.S. price cuts on drugmakers’ revenues.
A UK government spokesperson did not directly address the Financial Times report. But the spokesperson said in a statement that Britain was in “a constructive dialogue with the U.S. and industry.”<\/p>\n","protected":false},"excerpt":{"rendered":"
The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of U.S. President Donald Trump’s top complaints after he announced steep tariff increases on branded medication.British Prime Minister Keir Starmer’s chief business adviser, Varun Chandra, will travel […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-33429","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\n